Trial · NCT02688400
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change Form Baseline in WOMAC A Pain Subscale | baseline and 182 days | Change form baseline in Western Ontario and McMaster Universities Arthritis Index (WOMAC) A pain subscale after 182 days of treatment. WOMAC A pain subscale: 0 - 50 cm; 50 = worse |
| Secondary | Change From Baseline in WOMAC OA Scores | Day 182 or early termination | Absolute Changes from Baseline in Western Ontario and McMaster Universities Arthritis Index (WOMAC) after 182 days of treatment. WOMAC scale: 0 - 240 cm; 240 = worse - Intention-To-Treat (N=370) Pain subscale: 0-50cm; 50 = worse; Stifness subscale: 0-20cm; 20 = worse; Function subscale: 0-170cm; 170 = worse Absolute changes in WOMAC scores: \<0 = improvement; 0 = stable; \>0 = worsening |
| Secondary | Absolute Changes From Baseline in Pain Visual Analogue Scale | Day 182 or early termination | Absolute Changes from Baseline in Pain Visual Analogue Scale (VAS): 0-10 cm; 10 = worse |
| Secondary | OARSI Responders | Day 182 or early termination | Osteoarthritis Research Society International (OARSI) Responders |
| Secondary | Assessment of Joint Swelling, Effusion or Both | Day 182 or early termination | Assessment of Joint Swelling, joint Effusion or Both |
| Secondary | Consumption of Acetaminophen | Day 182 or early termination | Overall Daily number of tablets taken during the 6 month study |
| Secondary | Change From Baseline in Patient's Global Assessment of Disease Activity | Day 182 or early termination | Change from baseline in global assessment of disease activity was assessed using a VAS scale (0-10cm; 10=worse) |
| Secondary | Global Assessment of Response to Therapy | Day 182 or early termination | Between group comparison in Patient's and Investigator's Global Assessment of Response to Therapy using a 0-10 cm disease activity VAS scale: 0 cm = very well; 10 cm = very poorly |
| Secondary | Quality of Life SF-36 | Day 182 or early termination | Absolute Changes from Baseline in Physical Component Summary (PCS) and Mental Component Summary (MCS) scores from the Quality of Life questionnaire SF-36. Scale range for each component (PCS and MCS): minimum = 0, maximum = 100, with higher scores indicating better quality of life. Absolute changes in each component (PCS and MCS): \>0 = improvement; 0 = stable; \<0 = worsening. |
| Other | Cartilage Volume Loss From Baseline in the Medial Compartment Using MRI | baseline and 728 days | Relative cartilage volume loss from baseline in the medial compartment of the knee using MRI |
| Other | Cartilage Volume Loss From Baseline in the Lateral Compartment Using MRI | baseline and 728 days | Relative cartilage volume loss from baseline in the lateral compartment of the knne using MRI |
| Other | Change From Baseline in Synovitis (Synovial Membrane Thickness) Using MRI | baseline and 728 days | Absolute Change from baseline in synovitis (synovial membrane thickness) in the global knee using MRI |
| Other | Change From Baseline in WOMAC A Pain Subscale | baseline and 728 days | Relative mean change from baseline in WOMAC Pain subscore |
| Other | Change From Baseline in Global Stiffness Using WOMAC Subscale | baseline and 728 days | Relative Change from baseline in global stiffness using WOMAC subscale |
| Other | Change From Baseline in Visual Analogue Scale Pain (VAS-Huskisson's) | baseline and 728 days | Relative change from baseline in Visual Analogue Scale pain (VAS-Huskisson's) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02688400/registered